Michael Schachter

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
    Michael Schachter
    Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, St Mary s Hospital, London, W2 4NY, UK
    Fundam Clin Pharmacol 19:117-25. 2005
  2. ncbi Uric acid and hypertension
    Michael Schachter
    Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, St Mary s Hospital, London, UK
    Curr Pharm Des 11:4139-43. 2005
  3. pmc The epidemiology of medication errors: how many, how serious?
    Michael Schachter
    Department of Clinical Pharmacology, National Heart and Lung Institute International Centre for Circulatory Health, Imperial College, London, UK
    Br J Clin Pharmacol 67:621-3. 2009
  4. ncbi Strategies for modifying high-density lipoprotein cholesterol: a role for nicotinic acid
    Michael Schachter
    Department of Clinical Pharmacology, Imperial College of Science, Technology and Medicine, St Mary s Hospital, London, UK
    Cardiovasc Drugs Ther 19:415-22. 2005
  5. ncbi Spinning stars: ASTEROID's impact on atherosclerosis
    Michael Schachter
    Lancet 367:1655-6. 2006

Collaborators

Detail Information

Publications5

  1. ncbi Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
    Michael Schachter
    Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, St Mary s Hospital, London, W2 4NY, UK
    Fundam Clin Pharmacol 19:117-25. 2005
    ..Consideration of the differences between the statins helps to provide a rational basis for their use in clinical practice...
  2. ncbi Uric acid and hypertension
    Michael Schachter
    Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, St Mary s Hospital, London, UK
    Curr Pharm Des 11:4139-43. 2005
    ....
  3. pmc The epidemiology of medication errors: how many, how serious?
    Michael Schachter
    Department of Clinical Pharmacology, National Heart and Lung Institute International Centre for Circulatory Health, Imperial College, London, UK
    Br J Clin Pharmacol 67:621-3. 2009
    ..5. Computerized prescribing can help but can also generate its own inherent errors. 6. Improved training of prescribers at the undergraduate and postgraduate levels is vital, a fact that is now being belatedly recognized...
  4. ncbi Strategies for modifying high-density lipoprotein cholesterol: a role for nicotinic acid
    Michael Schachter
    Department of Clinical Pharmacology, Imperial College of Science, Technology and Medicine, St Mary s Hospital, London, UK
    Cardiovasc Drugs Ther 19:415-22. 2005
    ..Raising HDL-C will increasingly become an important secondary focus of dyslipidaemia management...
  5. ncbi Spinning stars: ASTEROID's impact on atherosclerosis
    Michael Schachter
    Lancet 367:1655-6. 2006